Chemotherapy, Host Response and Molecular Dynamics in Periampullary Cancer

CompletedOBSERVATIONAL

Enrollment

201

Participants

Timeline

Start Date

October 30, 2018

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

Periampullary AdenocarcinomaPeriampullary CancerPancreatic Cancer

Interventions

DRUG

Gemcitabine

Adjuvant or palliative chemotherapy according to national guidelines

Trial Locations (1)

Department of Oncology, Skåne University Hospital, Malmo

All Listed Sponsors

lead

Lund University

OTHER

NCT03724994 - Chemotherapy, Host Response and Molecular Dynamics in Periampullary Cancer | Biotech Hunter | Biotech Hunter